c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Tempus AI and AstraZeneca amend agreement with new five-year, $200 million commitment
Investing.com | Nov 18, 2026 8:46 AM EST
Read original article